QuidelOrtho appears to be selling trial shares as a medical PE company



The diagnostic company’s shares have fallen by 90% since its rapid antigen test was the first to be approved for Covid-19.



Source link

اترك ردّاً

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *